Source: Toxicology and Applied Pharmacology. Unidades: FCFRP, FMRP
Subjects: CANABINOIDES, MACRÓFAGOS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rangel Leal et al. DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor. Toxicology and Applied Pharmacology, v. 368, p. 63-71, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.taap.2019.02.011. Acesso em: 20 out. 2024.APA
Silva, R. L., Silveira, G. T., Wanderlei, C. W., Cecilio, N. T., Maganin, A. G. de M., Franchin, M., et al. (2019). DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor. Toxicology and Applied Pharmacology, 368, 63-71. doi:10.1016/j.taap.2019.02.011NLM
Silva RL, Silveira GT, Wanderlei CW, Cecilio NT, Maganin AG de M, Franchin M, Marques LMM, Lopes NP, Crippa JA de S, Guimarães FS, Alves-Filho JCF, Cunha F de Q, Cunha TM. DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor [Internet]. Toxicology and Applied Pharmacology. 2019 ; 368 63-71.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.taap.2019.02.011Vancouver
Silva RL, Silveira GT, Wanderlei CW, Cecilio NT, Maganin AG de M, Franchin M, Marques LMM, Lopes NP, Crippa JA de S, Guimarães FS, Alves-Filho JCF, Cunha F de Q, Cunha TM. DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor [Internet]. Toxicology and Applied Pharmacology. 2019 ; 368 63-71.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.taap.2019.02.011